Leakage of Medical Information and Violations of the Act on the Protection of Personal Information
First written in FY2019. 15 of 16 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2023: 4 of 15 companies on the "Worse" side.
19 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「The Company is taking thorough measures to build systems and educate employees to prevent the leakage of this information. However, if an incident violating the Act on the Protection of Personal Information were to occur, the Group could face lawsuits seeking damages or the suspension of transactions with business partners, potentially affecting its performance and financial condition.」
The Company continues to implement measures to prevent the leakage of medical information and diagnostic image data, and identifies the risks of lawsuits and suspended transactions in the event of a leak. - FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2024RestatedAnnual report
「The Company is taking thorough measures to build systems and educate employees to prevent the leakage of this information. However, if an incident violating the Act on the Protection of Personal Information were to occur, the Group could face lawsuits seeking damages or the suspension of transactions with business partners, potentially affecting its performance and financial condition.」
The Company continues to implement measures to prevent the leakage of medical information and diagnostic image data, and identifies the risks of lawsuits and suspended transactions in the event of a leak. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2023RestatedAnnual report
「The radiation department information management systems, electronic medical records and other medical information systems handled by the Group, as well as the diagnostic image data handled by its remote image diagnosis service business, contain patients' medical information. The Company is taking thorough measures to build systems and educate employees to prevent the leakage of this information. However, if an incident violating the Act on the Protection of Personal Information were to occur, the Group could face lawsuits seeking damages or the suspension of transactions with business partners, potentially affecting its performance and financial condition.」
The Company continues to build systems and educate employees to prevent the leakage of medical information and diagnostic image data, and identifies the risks of lawsuits and suspended transactions in the event of a leak. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risks of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risks of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2021RestatedAnnual report
「The Company is taking thorough measures to build systems and educate employees to prevent the leakage of this information. However, if an incident violating the Act on the Protection of Personal Information were to occur, it could result in lawsuits seeking damages and the suspension of transactions with business partners, potentially affecting the Group's performance and financial condition.」
The Company continues to build systems and educate employees to prevent the leakage of medical information and diagnostic image data, and identifies the risks of lawsuits and suspended transactions in the event of a leak. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2020-Q1RestatedAnnual report
「During the cumulative first quarter of the current consolidated fiscal year, there were no newly emerging business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company concludes that there have been no material changes regarding the risk of medical information leakage or violations of the Act on the Protection of Personal Information. - FY2019First statedAnnual report
「The Company is taking thorough measures to build systems and educate employees to prevent the leakage of this information. However, if an incident violating the Act on the Protection of Personal Information were to occur, it could result in lawsuits seeking damages and the suspension of transactions with business partners, potentially affecting the Group's performance and financial condition.」
The Company handles medical information systems containing patients' medical information and, while building systems and educating employees, identifies the possibility of lawsuits and suspension of transactions due to information leakage or violations of laws and regulations.